SCHEMBL3577494

SCHEMBL3577494

Oc1nnc(O)c(-c2ccc(Cl)cc2)c1-c1ccc(Cl)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.43
CYP1A2 P05177 3/20 0.40
LMNA P02545 1/20 0.40
CYP2A6 P11509 1/20 0.40
RPA1 P27694 1/20 0.39
KDM4E B2RXH2 3/20 0.38
MAPT P10636 3/20 0.38
HSD17B10 Q99714 2/20 0.38
MAPK1 P28482 2/20 0.38
ALDH1A1 P00352 2/20 0.38
IKBKB O14920 1/20 0.38
MAP3K14 Q99558 1/20 0.38
NOTUM Q6P988 2/20 0.38
TSHR P16473 2/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
GAA P10253 2/20 0.38
GRIN2D O15399 1/20 0.38
GRIN3B O60391 1/20 0.38
GRIN1 Q05586 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4391202 0.93 CASP1 (0.40) ALOX5CYP1A2LMNACYP2A6RPA1
SCHEMBL3583299 0.89 GCGR (0.50) LMNAKDM4EMAPTMAPK1RAB9A
SCHEMBL4395903 0.84 GCGR (0.46) LMNAKDM4EMAPK1RAB9AGAA
SCHEMBL3580926 0.82 NPC1 (0.39) ALOX5CYP1A2KDM4EMAPTHSD17B10
SCHEMBL3574012 0.79 NPC1 (0.44) CYP1A2LMNAKDM4EMAPK1NPC1
SCHEMBL4070584 0.76 KMO (0.42) ALOX5CYP1A2LMNACYP2A6KDM4E
SCHEMBL3561069 0.76 LMNA (0.47) CYP1A2LMNACYP2A6RPA1KDM4E
SCHEMBL4390766 0.75 L3MBTL1 (0.49) CYP1A2LMNAKDM4EMAPTHSD17B10
SCHEMBL3577417 0.75 NPC1 (0.42) KDM4EHSD17B10ALDH1A1TSHRNPC1
SCHEMBL11223011 0.74 LMNA (0.61) ALOX5CYP1A2LMNACYP2A6KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100022526-A1 PYRIDAZINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS FUNGICIDES SYNGENTA CROP PROTECTION, INC. (US) 2010-01-28 US disclosed
EP-2121628-A1 PYRIDAZINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS FUNGICIDES Syngenta Participations AG (CH) 2009-11-25 EP disclosed
WO-2008089934-A1 PYRIDAZINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS FUNGICIDES SYNGENTA PARTICIPATIONS AG (CH) 2008-07-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100022526-A1 PYRIDAZINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS FUNGICIDES CYP4Z1, CYP1A2, CYP1A1 ALOX5 2206/4885CYP1A2 2/4885LMNA 3036/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.